Home › Funds › RTW INVESTMENTS, LP › KLRA

RTW INVESTMENTS, LP position in KLRA

KAILERA THERAPEUTICS INC · Health Care

RTW INVESTMENTS, LP reported holding 10,776,820 shares of KLRA (KAILERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$123.1M, representing 1.24% of its reported portfolio and ranking #30 among its reported holdings. RTW INVESTMENTS, LP has disclosed KLRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)10.78M sh
Reported value held$123.07M
Portfolio Weight1.24%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's KLRA position evolved

RTW INVESTMENTS, LP first disclosed a stake in KLRA in Q2 2026 at 10,776,820 shares (US$237.4M). Across 2 filings, RTW INVESTMENTS, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 10,776,820 shares valued at US$123.1M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 10.78M $237.41M New
Q3 2026 10.78M $123.07M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KLRA and 13F data

KLRA (KAILERA THERAPEUTICS INC) is a Health Care company. 134 other funds we track also report a position in KLRA — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$299.8M), Bain Capital Life Sciences Investors, LLC (US$257.9M), Atlas Venture Life Science Advisors, LLC (US$59.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KLRA

All KLRA fund holders →

FAQ

How long has RTW INVESTMENTS, LP held KLRA?

RTW INVESTMENTS, LP has disclosed KLRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is RTW INVESTMENTS, LP's current position in KLRA?

As of Q3 2026, RTW INVESTMENTS, LP holds 10.78M shares of KLRA (KAILERA THERAPEUTICS INC), valued at $123.07M, representing 1.24% of its reported portfolio and ranking #30.

Has RTW INVESTMENTS, LP been buying or selling KLRA?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in KLRA.

Which other funds hold KLRA?

Other major institutional holders of KLRA include BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, Atlas Venture Life Science Advisors, LLC, among 134 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.